Jacobs Levy Equity Management’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Jacobs Levy Equity Management’s Portfolio RVLP Stock Details RVLP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-339,129	Closed	-$1.02M	–	1145
2021 Q2	$1.02M	Sell	339,129 -69,489	-17%	-$213K	0.01%	737
2021 Q1	$1.33M	Buy	+408,618	New	+$1.68M	0.01%	672
2020 Q3	–	Sell	-14,250	Closed	-$96K	–	1125
2020 Q2	$96K	Sell	14,250 -77,915	-85%	-$381K	﹤0.01%	1011
2020 Q1	$293K	Buy	92,165 +10,600	+13%	+$56.5K	﹤0.01%	832
2019 Q4	$570K	Buy	81,565 +57,115	+234%	+$305K	0.01%	769
2019 Q3	$94K	Sell	24,450 -12,849	-34%	-$43.5K	﹤0.01%	894
2019 Q2	$142K	Buy	+37,299	New	+$124K	﹤0.01%	903

Other funds holding RVLP

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Rovida Advisors Fort Lauderdale, Florida $116M AUM 12.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Jacobs Levy Equity Management's RVLP Position: Q3 2021 in Review

Jacobs Levy Equity Management sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q3 2021, closing a stake of 339,129 shares — an estimated $1.02M sold.

Jacobs Levy Equity Management first reported a position in RVLP in Q2 2019 and held it in 7 quarters. The position peaked at $1.33M in Q1 2021. 35 funds tracked by Wall St. Rank hold RVLP as of Q3 2021.

Jacobs Levy Equity Management reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q3 2021 after selling out during the quarter.
Jacobs Levy Equity Management sold 339,129 RVL Pharmaceuticals plc Ordinary Shares shares in Q3 2021, an estimated $1.02M.
Jacobs Levy Equity Management first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q2 2019 and held it in 7 quarters.
Jacobs Levy Equity Management's RVL Pharmaceuticals plc Ordinary Shares position peaked at $1.33M in Q1 2021.
35 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q3 2021.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2021, filed 15 Nov 2021.